June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
August 2026
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
September 2026
The U.S. over the counter (OTC) drugs market size stood at USD 26 billion in 2026, with major U.S. over the counter (OTC) drugs companies including bayer ag, Pfizer, johnson & johnson services inc, Sanofi sa, Novartis ag.
September 2026
The rheumatoid arthritis drugs market size reached USD 65.51 billion in 2026, with leading rheumatoid arthritis drugs market companies including AbbVie Inc., Sun Pharma, Lupin.
September 2026
The drug discovery informatics market size stood at USD 5.35 billion in 2026, with major drug discovery informatics companies including collaborative drug discovery inc, eurofins discoverx products, jubilant biosys, selvita, novo informatics pvt ltd.
September 2026
The computational medicine and drug discovery software market size reached USD 10.90 billion in 2025, with leading computational medicine and drug discovery software market companies including Entelos Inc., Crown Bioscience Inc., Chemical Computing Group Inc., Nimbus Therapeutics Inc.
August 2026
The pulmonary drug delivery systems market size reached USD 61.03 billion in 2026, with leading pulmonary drug delivery systems market companies including Philips Respironics, GlaxoSmithKline PLC, BoehringerIngelheim GmbH.
August 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
August 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
August 2026
The chemical drug CDMO market size was USD 13.20 billion in 2025, with leading chemical drug CDMO market players including Almac Group, BASF SE, Boehringer Ingelheim, Cipla Limited.
August 2026
The contraceptive drugs market size reached USD 20.12 billion in 2026, with leading contraceptive drugs market companies including Pfizer Inc., Bayer AG, Merck and Co. Inc.
August 2026
The amylin analog drugs market size stood at USD 3.20 billion in 2025, with major Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Novartis AG. companies including amylin analog drugs market.
August 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
August 2026
The genitourinary drugs market size was USD 30.37 billion in 2026, with leading genitourinary drugs market players including Pfizer inc, johnson & johnson, bayer ag, Sanofi.
August 2026
The ovarian cancer drugs market reached USD 4.09 billion in 2025, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
August 2026
The pulmonary alveolar proteinosis (PAP) drugs market reached USD 859.05Â million in 2026, with key pulmonary alveolar proteinosis (PAP) drugs market companies including Savara, Inc., Partner Therapeutics, Inc., Nobelpharma Co., Ltd. Amgen Inc
August 2026
The global precision oncology market size is calculated at USD 133 billion in 2025 and is projected to hit around USD 338.89 billion by 2035 with a CAGR of 11.33%.
August 2026
The drug discovery services market size was estimated at USD 24.26 billion in 2025 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
August 2026
The global antibody drug conjugates market size is projected to hit around USD 34.80 billion by 2035 from USD 12.69 billion in 2025 with a soild CAGR of 10.61%.
August 2026
The artificial intelligence (AI) in oncology market size is expected to hit around USD 21.36 billion by 2035 from USD 1.87 billion in 2025 with a CAGR of 27.58%.
August 2026
The global subcutaneous drug delivery devices market size was valued at USD 36.12 billion in 2025 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
August 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
August 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
August 2026
The Europe over the counter (OTC) drugs market size is calculated at USD 41.44 billion in 2025 and is predicted to attain around USD 74.56 billion by 2035, expanding at a CAGR of 6.05%.
August 2026
The India immunotherapy drugs market size accounted for USD 11.8 billion in 2025 and is predicted to touch around USD 73.67 billion by 2035, growing at a CAGR of 20.10%.
August 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 792.67 million in 2025, with a CAGR of 9.00%.
August 2026
The drug delivery devices market size reached USD 321.05 billion in 2026, with leading drug delivery devices market companies including Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd.
August 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
August 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.07 trillion in 2025 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com